Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
Clinical trial NCT00418132 · TERMINATED
Trial details
- NCT number
- NCT00418132
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.